TRPA1 mediates the anti-inflammatory effects of N-Acylethanolamine in a COX-2-dependent manner in rheumatoid arthritis [43], as inactivation of COX-2 and other mediators is associated with alleviation of IVDD [44]. Here, TRPA1 is linked to rheumatoid arthritis.